tiprankstipranks
Holding GB:BIOT?
Track your performance easily

GB:BIOT Price & Analysis

BIOT ETF Chart & Stats

Day’s Range― - ―
52-Week Range$9.04 - $11.22
Previous Close$9.8
VolumeN/A
Average Volume (3M)3.65K
AUM17.22M
NAV9.80
Expense Ratio0.49%
Holdings Count43
Beta0.70
Inception DateJan 23, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding1,936,462
Standard Deviation0.06
10 Day Avg. Volume1,716
30 Day Avg. Volume3,653
Alpha0.01

L&G Pharma Breakthrough UCITS ETF (BIOT) Fund Flow Chart

L&G Pharma Breakthrough UCITS ETF (BIOT) 1 year Net Flows: -$25M

BIOT ETF FAQ

What was GB:BIOT’s price range in the past 12 months?
GB:BIOT lowest ETF price was $9.04 and its highest was $11.22 in the past 12 months.
    What is the AUM of GB:BIOT?
    As of Jul 03, 2024 The AUM of GB:BIOT is 17.22M.
      Is GB:BIOT overvalued?
      According to Wall Street analysts GB:BIOT’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does GB:BIOT pay dividends?
        GB:BIOT does not currently pay dividends.
        How many shares outstanding does GB:BIOT have?
        GB:BIOT has 1,936,462 shares outstanding.
          Which hedge fund is a major shareholder of GB:BIOT?
          Currently, no hedge funds are holding shares in GB:BIOT

          ETF Description

          L&G Pharma Breakthrough UCITS ETF

          The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
          Sector
          Sector
          Asset Class
          Equity
          Region
          Global
          Issuer
          L&G
          Index Tracked
          Solactive Pharma Breakthrough Value Index
          Ticker Symbol
          GB:BIOT
          Popular ETFs
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis